Literature DB >> 22560214

Nuclear receptors reverse McGarry's vicious cycle to insulin resistance.

David D Moore1.   

Abstract

Several pathways and pathologies have been suggested as connections between obesity and diabetes, including inflammation of adipose and other tissues, toxic lipids, endoplasmic reticulum stress, and fatty liver. One specific proposal is that insulin resistance induces a vicious cycle in which hyperinsulinemia increases hepatic lipogenesis and exacerbates fatty liver, in turn further increasing insulin resistance. Here I suggest that reversing this cycle via suppression of the lipogenic transcription factor SREBP-1c is a common thread that connects the antidiabetic effects of a surprising number of nuclear hormone receptors, including CAR, LRH-1, TRβ, ERα, and FXR/SHP.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22560214      PMCID: PMC3613429          DOI: 10.1016/j.cmet.2012.03.016

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  122 in total

Review 1.  Role of glucocorticoids and the glucocorticoid receptor in metabolism: insights from genetic manipulations.

Authors:  Adam J Rose; Alexandros Vegiopoulos; Stephan Herzig
Journal:  J Steroid Biochem Mol Biol       Date:  2010-02-17       Impact factor: 4.292

2.  Molecular control of systemic bile acid homeostasis by the liver glucocorticoid receptor.

Authors:  Adam J Rose; Mauricio Berriel Díaz; Anja Reimann; Johanna Klement; Tessa Walcher; Anja Krones-Herzig; Oliver Strobel; Jens Werner; Achim Peters; Anna Kleyman; Jan P Tuckermann; Alexandros Vegiopoulos; Stephan Herzig
Journal:  Cell Metab       Date:  2011-07-06       Impact factor: 27.287

3.  Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways.

Authors:  Jessica L Yecies; Hui H Zhang; Suchithra Menon; Sihao Liu; Derek Yecies; Alex I Lipovsky; Cem Gorgun; David J Kwiatkowski; Gökhan S Hotamisligil; Chih-Hao Lee; Brendan D Manning
Journal:  Cell Metab       Date:  2011-07-06       Impact factor: 27.287

Review 4.  Vitamin D and diabetes.

Authors:  Tatiana Takiishi; Conny Gysemans; Roger Bouillon; Chantal Mathieu
Journal:  Endocrinol Metab Clin North Am       Date:  2010-06       Impact factor: 4.741

5.  Dissection of the insulin-sensitizing effect of liver X receptor ligands.

Authors:  S Renee Commerford; Leo Vargas; Suzanne E Dorfman; Nico Mitro; Erik C Rocheford; Puiying A Mak; Xue Li; Patrick Kennedy; Tara L Mullarkey; Enrique Saez
Journal:  Mol Endocrinol       Date:  2007-08-23

6.  Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue.

Authors:  Vanessa P Houde; Sophie Brûlé; William T Festuccia; Pierre-Gilles Blanchard; Kerstin Bellmann; Yves Deshaies; André Marette
Journal:  Diabetes       Date:  2010-03-18       Impact factor: 9.461

7.  Anti-obesity, anti-diabetic, and lipid lowering effects of the thyroid receptor beta subtype selective agonist KB-141.

Authors:  Galina Bryzgalova; Suad Effendic; Akhtar Khan; Stefan Rehnmark; Peter Barbounis; Jamie Boulet; Gao Dong; Rajni Singh; Sue Shapses; Johan Malm; Paul Webb; John D Baxter; Gary J Grover
Journal:  J Steroid Biochem Mol Biol       Date:  2008-06-22       Impact factor: 4.292

Review 8.  Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications.

Authors:  Elisa Fabbrini; Shelby Sullivan; Samuel Klein
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

9.  Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c.

Authors:  Guosheng Liang; Jian Yang; Jay D Horton; Robert E Hammer; Joseph L Goldstein; Michael S Brown
Journal:  J Biol Chem       Date:  2002-01-08       Impact factor: 5.157

10.  Therapeutic potential of retinoid x receptor modulators for the treatment of the metabolic syndrome.

Authors:  Jane A Pinaire; Anne Reifel-Miller
Journal:  PPAR Res       Date:  2007-03-28       Impact factor: 4.964

View more
  18 in total

Review 1.  Dissociating fatty liver and diabetes.

Authors:  Zheng Sun; Mitchell A Lazar
Journal:  Trends Endocrinol Metab       Date:  2012-10-05       Impact factor: 12.015

Review 2.  Nutrient-sensing nuclear receptors PPARα and FXR control liver energy balance.

Authors:  Geoffrey A Preidis; Kang Ho Kim; David D Moore
Journal:  J Clin Invest       Date:  2017-03-13       Impact factor: 14.808

3.  Sterol regulatory element-binding protein-1 (SREBP-1) is required to regulate glycogen synthesis and gluconeogenic gene expression in mouse liver.

Authors:  Rafaela Ruiz; Victoria Jideonwo; Miwon Ahn; Sneha Surendran; Vincent S Tagliabracci; Yongyong Hou; Aisha Gamble; Janos Kerner; José M Irimia-Dominguez; Michelle A Puchowicz; Anna DePaoli-Roach; Charles Hoppel; Peter Roach; Núria Morral
Journal:  J Biol Chem       Date:  2014-01-07       Impact factor: 5.157

4.  MicroRNA-26a regulates insulin sensitivity and metabolism of glucose and lipids.

Authors:  Xianghui Fu; Bingning Dong; Yan Tian; Philippe Lefebvre; Zhipeng Meng; Xichun Wang; François Pattou; Weidong Han; Xiaoqiong Wang; Fang Lou; Richard Jove; Bart Staels; David D Moore; Wendong Huang
Journal:  J Clin Invest       Date:  2015-05-11       Impact factor: 14.808

5.  Small heterodimer partner deletion prevents hepatic steatosis and when combined with farnesoid X receptor loss protects against type 2 diabetes in mice.

Authors:  Oludemilade Akinrotimi; Ryan Riessen; Philip VanDuyne; Jung Eun Park; Yoon Kwang Lee; Lee-Jun Wong; Ann M Zavacki; Kristina Schoonjans; Sayeepriyadarshini Anakk
Journal:  Hepatology       Date:  2017-10-30       Impact factor: 17.425

6.  Physiological Suppression of Lipotoxic Liver Damage by Complementary Actions of HDAC3 and SCAP/SREBP.

Authors:  Romeo Papazyan; Zheng Sun; Yong Hoon Kim; Paul M Titchenell; David A Hill; Wenyun Lu; Manashree Damle; Min Wan; Yuxiang Zhang; Erika R Briggs; Joshua D Rabinowitz; Mitchell A Lazar
Journal:  Cell Metab       Date:  2016-11-17       Impact factor: 27.287

7.  Gestational Cd Exposure in the CD-1 Mouse Induces Sex-Specific Hepatic Insulin Insensitivity, Obesity, and Metabolic Syndrome in Adult Female Offspring.

Authors:  Thomas W Jackson; Garret L Ryherd; Chris M Scheibly; Aubrey L Sasser; T C Guillette; Scott M Belcher
Journal:  Toxicol Sci       Date:  2020-12-01       Impact factor: 4.849

Review 8.  Deciphering the roles of the constitutive androstane receptor in energy metabolism.

Authors:  Jiong Yan; Baian Chen; Jing Lu; Wen Xie
Journal:  Acta Pharmacol Sin       Date:  2014-12-15       Impact factor: 6.150

Review 9.  Farnesoid X receptor: a master regulator of hepatic triglyceride and glucose homeostasis.

Authors:  Yang Jiao; Yan Lu; Xiao-ying Li
Journal:  Acta Pharmacol Sin       Date:  2014-12-15       Impact factor: 6.150

Review 10.  Thyroid hormone regulation of metabolism.

Authors:  Rashmi Mullur; Yan-Yun Liu; Gregory A Brent
Journal:  Physiol Rev       Date:  2014-04       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.